Oropharyngeal Carcinoma
📧 Sign up to get email alerts when something new happens for Oropharyngeal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Update: Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers [Phase 2, Phase 3]
Phase 2/3 trial evaluating atezolizumab and/or bevacizumab with or without standard chemotherapy as second-line treatment for advanced head …
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer [Phase 1]
This Phase 1 trial update reports termination of the INBRX-105 in combination with pembrolizumab across multiple solid tumors, including hea…
-
CLINICAL_TRIALS trial_result · 2022-04-04Clinical Trial Update: Anti-EGFR Therapy With IMRT Concurrent Chemoradiotherapy in Locally Advanced OPC Resistant to Induction Chemotherapy [Phase 2]
Phase 2 trial evaluating anti-EGFR therapy with IMRT concurrent chemoradiotherapy in locally advanced oropharyngeal carcinoma resistant to i…
-
CLINICAL_TRIALS trial_result · 2020-05-05Clinical Trial Update: Neo-adjuvant Erbitux-based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer [Phase 2]
Phase 2 trial update on neoadjuvant Erbitux-based chemotherapy for locally advanced oral/oropharyngeal cancer has completed.